Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin

Tilman Schneider-Poetsch, Jianhua Ju, Daniel E. Eyler, Yongjun Dang, Shridhar Bhat, William C. Merrick, Rachel Green, Ben Shen, Jun O. Liu

Research output: Contribution to journalArticlepeer-review

Abstract

Although the protein synthesis inhibitor cycloheximide (CHX) has been known for decades, its precise mechanism of action remains incompletely understood. The glutarimide portion of CHX is seen in a family of structurally related natural products including migrastatin, isomigrastatin and lactimidomycin (LTM). We found that LTM, isomigrastatin and analogs have a potent antiproliferative effect on tumor cell lines and selectively inhibit translation. A systematic comparative study of the effects of CHX and LTM on protein synthesis revealed both similarities and differences between the two inhibitors. Both LTM and CHX were found to block the translocation step in elongation. Footprinting experiments revealed protection of a single cytidine nucleotide (C3993) in the E-site of the 60S ribosomal subunit, thus defining a common binding pocket for the two inhibitors in the ribosome. These results shed new light on the molecular mechanism of inhibition of translation elongation by both CHX and LTM.

Original languageEnglish (US)
Pages (from-to)209-217
Number of pages9
JournalNature chemical biology
Volume6
Issue number3
DOIs
StatePublished - Mar 2010

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Fingerprint

Dive into the research topics of 'Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin'. Together they form a unique fingerprint.

Cite this